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Abstract 
 
Background: Healthcare workers (HCWs) are considered at elevated risk of experiencing 
mental health disorders in working with patients with COVID-19.  
 
Objective: To estimate the prevalence of common mental health disorders in HCWs based in 
hospitals where pandemic-affected patients were treated.  
 
Method: Databases were searched for studies published before 30th March 2020. Quantitative 
synthesis was used to obtain estimates of the prevalence of mental health disorders in four 
time windows, determined a priori (the acute phase, i.e. during and up to 1.5 months post-
pandemic; 1.5-5.9 months; 6-11.9 months; 12 months and later).  
 
Results: Nineteen studies met the review criteria. They predominantly addressed the acute 
phase of the SARS outbreak in Asia. The most studied outcomes were clinically-significant 
post-traumatic stress symptoms (PTSS) and general psychiatric caseness. For clinically 
significant PTSS in the acute phase, the prevalence estimate was 23.4% (95% CI 16.3, 31.2; 
N=4147; I2=96.2%); in the 12 months plus window, the estimate was 11.9% (8.4, 15.8; 
N=1136; I2=74.3%). For general psychiatric caseness, prevalence estimates were: acute 
phase, 34.1% (18.7, 51.4; N=3971; I2=99.1%); 6-12 months, 17.9% (13.1, 23.2; N=223; 
I2=0.0%); 12 months plus, 29.3% (6.0, 61.0; N=710; I2=97.8%). No differences between 
doctors and nurses with respective to PTSS and general psychiatric caseness were apparent in 
the acute phase. 
 
Conclusions: Mental health disorders are particularly common in HCWs working with 
pandemic-afflicted patients immediately following a pandemic, but the course of disorders 
following this period is poorly understood. There was considerable heterogeneity between 
studies, likely linked to methodological differences. More extended follow up of HCWs is 
needed. 
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Introduction 
 
 Healthcare workers (HCWs) including nurses, doctors, allied health professionals and 
all support staff based in hospitals where patients with COVID-19 are treated face 
considerable challenges and stress. In addition to the clinical challenges associated with 
treating a large volume of severely unwell patients, HCWs working with this group of 
infectious patients face threats to their own physical health1, with a number of highly 
publicised HCW deaths already reported due to COVID-19. There is increasing recognition 
of the significant psychological impact of caring for those with COVID-19 given the 
immense pressure facing HCWs. For example, HCWs may face situations where they are at 
risk of sustaining moral injury2, while there are also difficulties in obtaining sufficient 
personal protective equipment.3 Health systems are subsequently implementing mental health 
provision systems and additional psychological support4.  
In order to better plan and develop these support systems, and to assist with education 
around reactions to working with COVID-19 patients, a rapid systematic review was 
undertaken to determine the prevalence of mental health disorders in HCWs working with 
patients infected through a pandemic. The review was focused on common mental health 
difficulties, such as post-traumatic stress, anxiety and depression, to allow an accurate 
prevalence of future demand on mental health services and to inform the provision of 
evidence-based interventions. We broadened our search to include studies relevant to the 
current COVID-19 crisis, e.g. pertaining to other coronavirus outbreaks (Severe Acute 
Respiratory Syndrome [SARS], Middle East Respiratory Syndrome [MERS]) and other 
epidemics that represent significant risks to HCWs (e.g. Ebola). In particular we sought to 
establish the prevalence of different conditions at different phases, i.e. during and 
immediately after a pandemic, then over the following months.  
 In summary, the aim of this rapid systematic review was to estimate the prevalence of 
common mental health disorders (in particular post-traumatic stress, depression, anxiety or 
general psychopathology) in HCWs working in hospitals with patients infected through a 
pandemic in the period during or following the pandemic. 
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Method 
 
Protocol and registration. 
 The present review was not pre-registered given the perceived need to disseminate a 
rapid review pertaining to the mental health consequences for HCWs given the exponential 
rise in hospital admissions and deaths for COVID-19. The review was produced in 
accordance with Preferred Reporting Items for Systematic Reviews and Meta-analysis 
(PRISMA) recommendations5.  
 
Eligibility criteria. 
 Studies were included in the present review if they measured the prevalence of mental 
health disorders (in particular clinically significant post-traumatic stress, depression, anxiety 
or general psychopathology) in healthcare workers that worked in a hospital where care was 
provided to patients who had acquired an infection because of a pandemic, e.g. SARS, 
MERS, Ebola, COVID-19. No restrictions were placed on healthcare worker type (e.g. 
medical and non-medical staff were included) or department worked in.  
Studies, or partial study data, were excluded if they: i) focused exclusively on 
healthcare workers who had also developed the index illness at the centre of the pandemic; ii) 
the sample included in-patients with the index infection; iii) the study was not published in 
English; iv) the study reported on stress or occupational wellbeing measures, such as burnout, 
rather than a diagnosable or clinical significant mental health disorder; v) participants 
included staff at other non-affected hospitals; vi) only comprised qualitative data; or vii) 
addressed work with pandemics with different routes of transmission to COVID-19 e.g. 
sexually transmitted or blood-borne pathogens including human immunodeficiency virus 
(HIV).  
 
Information source. 
 Databases searched included Medline, PsycINFO, CINAHL, PubMed, OVID and 
ScienceDirect.  Manual searches of relevant review papers and empirical articles were also 
carried out to identify any studies that had not yet been included in the literature databases. 
 
Search.  
 Search terms were 1) terms related to identified pandemics (including SARS, MERS, 
Coronavirus, Ebola and ‘pandemic’) AND 2) ‘acute hospital (including all search engine 
variants) AND 3) ‘mental health’ (including post traumatic stress, depression, anxiety and 
low mood variants) AND 4)‘health* professional’ (including variants such as doctor and 
nurse). Searches were conducted on 30th March 2020 with databases searched from 
inception. See Supplementary Material 1 for full search terms. 
 
Data collection process.  
 Duplicates were removed from search results. Titles and abstracts were screened for 
eligibility. The full texts of eligible studies were then accessed and checked against the 
inclusion and exclusion criteria. Six researchers were split into pairs (SA and RB, JB and SP, 
and TC and GS), both of whom independently completed initial screening and data 
extraction. Disagreements were resolved by discussion with the wider team and a decision 
reached by consensus.  
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Data items.  
 Descriptive data was extracted pertaining to key study characteristics (country and 
year of publication, pandemic, sex and role of participants, method of data collection). Data 
from comparison control groups (e.g. HCWs at another hospital that did not work with 
pandemic patients) were not extracted. Following our initial searches, the main outcomes we 
opted to consider were prevalence of clinically significant PTSS, depression, anxiety and 
general psychiatric caseness (i.e. scoring above cut-off on a general psychiatric screening 
questionnaire, such as the General Health Questionnaire). Prevalence data were therefore 
extracted for post-traumatic stress symptoms (PTSS), depression, anxiety and general 
psychiatric screening using the number of participants who scored above a defined cut-off on 
the given outcome measure or met threshold for a diagnosis based on a structured interview. 
Data were categorised according to four time periods, which were defined a priori: during the 
pandemic up to 1.49 months later (termed the ‘acute phase’); 1.5- 5.9 months; 6-11.9 months; 
and 12 months or later. The end point for each pandemic was defined by the individual 
studies themselves; studies usually cited the World Health Organisation having declared their 
region as being removed from the infected areas. 
 
Risk of bias.  
 The quality of the included papers was assessed using an adapted version of the 
National Heart, Lung and Blood Institute Quality Assessment Tool for Observational Cohort 
and Cross-Sectional Studies (https://www.nhlbi.nih.gov/health-topics/study-quality-
assessment-tools; see Supplementary Material 2 for full rating scheme). The assessment 
criteria included: study population defined; participation rate of over 50%; if follow-up, was 
the attrition rate described; and validity and reliability of measures for post traumatic stress, 
anxiety, depression and general psychiatric screen. Individual studies were scored for quality 
(0= not present/poor description, 1= some description but some missing information, 2= all 
desired information included) for each area of quality. Studies were given a percentage 
according to the degree of criteria being met. The percentage was used to indicate the study 
quality (>70% high, 50-69% medium, <50% low). 
Quality assessment and extraction were double rated; there were no disagreements on quality 
rating. 
Given how few studies were included in each meta-analysis (less than the 10 
suggested for funnel plot asymmetry)6, formal tests of publication bias are not reported.  
 
Summary measures.  
 The summary measure of interest was prevalence of a mental health difficulty, based 
on number scoring above cut-off on a self-report questionnaire measure (i.e. clinically 
significant levels of symptoms) or the number meeting diagnostic threshold based on a 
structured interview. Absolute prevalence was selected to be our outcome as we sought to 
determine the mental health burden for HCWs of working with patients infected through a 
pandemic, to inform the planning of support services. Comparison between pandemic-
affected and non-pandemic-affected hospitals was not possible as we did not find any studies 
that reported prevalence rates in any control hospitals. 
 
Synthesis of results.  
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 Prevalence outcomes were synthesised using a random-effects meta-analysis. Arcsine 
transformations was used to account for issues with study weightings when estimating 
prevalence7, with back-transformed values presented in all results. The metafor package8 in R 
3.4.29 was used to conduct the meta-analysis.  
 
Additional analyses. 
 Given significant heterogeneity in the literature, the post-hoc decision was undertaken 
to conduct sensitivity analyses. These involved restricting our quantitative syntheses to 
SARS-only literature and particular measures, and where possible reporting results by HCW 
profession groups.   
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Results 
 
Study selection.  
The numbers of studies screened, assessed for eligibility, and included in the review, 
with reasons for exclusions at each stage, are presented in a PRISMA flowchart (see Figure 
1). Nineteen studies provided usable data. Two articles related to the same cohort but at 
different time intervals10 11; these are therefore reported as a single study.  
One group reported two articles on the same hospital but the sampling frame for the 
follow up study was so different to the first that these articles are reported separately12 13. The 
same Canadian study group also reported follow up data on a smaller sub-set of participants 
but using structured interviews rather than self-report questionnaire screening14; a separate 
note on this additional study is provided below. References for all articles included in the 
review are provided in Supplementary Material 3.  
 
Study characteristics.  
 Nineteen studies met inclusion criteria for this review, comprising 8550 HCWs. Study 
characteristics are reported Table 1. The majority of included studies related to the SARS 
pandemic in Asian hospitals. SARS is a condition associated with coronavirus infection 
(SARS-CoV), characterised by a high transmission rate to HCW’s and with similar 
presenting symptoms to COVID-19 (e.g. dry cough, shortness of breath). The main 
transmission route and the progression for patients with severe disease are similar in both 
COVID-19 infection and SARS. One study reported findings from the COVID-19 pandemic. 
One set of studies pertained to the SARS outbreak in Canada, and a further study pertained to 
the H1N1 pandemic in Greece. All but two studies involved mixed healthcare worker 
samples; the remaining two focused exclusively on nurses. Reported outcomes were 
classified as being related to PTSS, depression, anxiety or a general psychiatric screen. Three 
studies reported that mental health interventions were offered to HCWs in response to the 
pandemic.  
 
Risk of bias within studies. 
Overall, eight studies were rated as high quality, eight as medium quality and two as 
low quality (Table 1; see Supplementary Material 4 for full quality ratings). The majority of 
studies (15 of 18) were judged to have clearly specified their study population. Ten of the 
studies had a participation rate greater than 50%. All assessment tools were self-report 
questionnaire measures; one study used a structured interview with a sub-set of HCWs, which 
will be reported separately. In only two studies was it explicitly stated that a PTSS measure 
was completed in relation to the relevant pandemic. 
 
Prevalence of psychiatric disorders. 
 Prevalence of clinically significant post-traumatic stress symptoms (PTSS). Nine 
studies were used to derive prevalence estimates for PTSS in the acute phase and two in the 
12 months onwards window; single studies addressed the 1.5-5.9 and 6-11.9m windows. 
Forest plots for each time window are displayed in Figure 2. The pooled estimate for 
clinically significant PTSS in the acute phase (i.e. during the pandemic itself and up to 1.5 
months after the end of the pandemic) was 23.4% (95% CI, 16.3, 31.2; k=9; N=4147; Chan et 
al 2004, Chen et al 2005, Lai et al 2020, Lee et al 2018, Lin et al 2007, Maunder et al 2004, 
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Sim et al 2004, Sin et al 2004, Su et al 2007). The pooled studies had a large degree of 
heterogeneity (Q[8] = 190.00, p < .0001; I2=96.2%). A single study addressed the 1.5-5.9m 
window (57.1%; 95% CI 49.1, 65.0; N= 147; Jung et al. 2020), and a single study also 
addressed the 6-11.9m window (17.7%; 95% CI 10.8, 25.9; N=96; Phua et al. 2005).  
The pooled estimate for the period 12 months onwards was 11.9% (95% CI 8.4, 15.8; 
k=2; N=1136; Liu et al 2012, Maunder et al 2006). The pooled studies had a large degree of 
heterogeneity (Q[1] = 3.89, p<.05; I2=74.3%). One of these studies14 also conducted 
structured clinical interviews for PTSD with a sub-set of HCWs in Toronto (139 of 587; 
24%). Two HCWs met criteria for current PTSD, with one identifying the SARS experience 
as the most severe traumatic event. 
Prevalence of anxiety. One study reported the prevalence of clinically significant 
anxiety in the acute phase, as measured by the GAD-715 (12.3%; 95% CI 10.5, 14.1; N=1257; 
Lai et al. 2020).  
Prevalence of depression. Two studies were used to derive the prevalence estimate 
for depression in the acute phase; one study addressed the 12 months onwards window. 
Forest plots for each time window are displayed in Supplementary Material 5. The pooled 
estimate for depression in the acute phase was 20.2% (95% CI 9.5, 33.7; k=2; N=1359). The 
pooled studies had a large degree of heterogeneity (Q[1] = 9.26, p<0.003; I2=89.2%). A 
further study considered the prevalence of depression in the 12 month onwards window 
(8.7%; 95% CI 6.5, 11.3; N=549; Liu et al. 2012). In their study that utilised structured 
interviews for psychiatric disorders, Lancee and colleagues14 found that there was one new 
case with a major depressive episode, among 93 HCWs who reported no pre-SARS mental 
health disorders. 
Prevalence of general psychiatric screening cases. Eight studies were used to derive 
the prevalence estimate for general psychiatric caseness within the acute phase, two in the 6-
12m window and two in the 12 months onwards window. Forest plots for each time window 
are displayed in Figure 3. The pooled estimate for the prevalence of positive cases on general 
psychiatric screening instruments in the acute phase was 34.1% (95% CI 18.7, 51.4; k=8, 
N=3971; Chan et al 2004, Chong et al 2004, Goulia et al 2010, Lin et al 2007, Nickell et al 
2004, Sim et al 2004, Sin et al 2004, Tam et al 2004). The pooled studies had a large degree 
of heterogeneity (Q[7] = 1199.28, p<0.0001; I2=99.1%).  
For the 6 to 12 month window the pooled estimate was 17.9% (95% CI 13.1, 23.2; 
k=2; N=223; Lu et al 2009/Lung et al 2009, Phua et al 2005), with no significant 
heterogeneity (Q[1] = 0.08, p= 0.78; I2=0.0%). For the 12 months onwards window, the 
pooled estimate was 29.3% (95% CI 6.0, 61.0; k=2; N=710; Maunder et al 2006, Lu et al 
2006/Lung et al 2009). These studies were associated with a large degree of heterogeneity 
(Q[1]=44.60, p<.0001; I2=97.8%). Maunder and colleagues (2006)  used a relatively low 
threshold for indicating caseness, possibly inflating the numbers that screened positive 
(44.9%); when applying the same criteria to a hospital not affected by the SARS epidemic, 
the authors found a large proportion (30.2%) scored above this threshold.  
Prevalence by profession. Further meta-analyses were conducted to consider 
whether prevalence differed by profession. These were restricted to the acute phase given 
how little data was available at follow up. The main professions considered were doctors and 
nurses. Regarding clinically significant PTSS the prevalence estimate for doctors was 18.7% 
(95% CI=6.0, 36.4; k=3; N=698; Chan et al. 2004, Lai et al. 2020, Sim et al. 2004), while for 
nurses it was 21.4% (95% CI 13.0, 31.3; k=5; N=1686; Chan et al. 2004, Chen et al. 2005, 
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Lai et al. 2020, Sim et al. 2004, Su et al. 2007); for the 3 studies that included both doctors 
and nurses, there was no difference in prevalence (odds ratio = .87 [95% CI .71, 1.08]; Chan 
et al. 2004, Lai et al. 2020, Sim et al. 2004). Regarding general psychiatric screening cases 
the estimate for doctors was 31.6% (95% CI 13.8, 52.7; k=5; N=508; Chan et al. 2004, 
Chong et al. 2004, Goulia ea al. 2010, Nickell et al. 2004, Sim et al. 2004), while for nurses it 
was 38.2% (95% CI 19.0, 59.4; k=5; 1683; Chan et al. 2004, Chong et al. 2004, Goulia ea al. 
2010, Nickell et al. 2004, Sim et al. 2004); there was no significant in prevalence between 
nurses and doctors (the same five studies; odds ratio = 1.29 [95% CI=0.45, 1.32]).  
Exploratory sub-group analyses in the acute phase. 
Given the significant heterogeneity present for most of the meta-analyses conducted, 
exploratory sub-group analyses were undertaken to see if more consistent findings might be 
discernible. Such analyses were only possible in relation to the acute phase. Moderator 
analyses were not undertaken given how few studies were available. 
First, meta-analyses were undertaken that included only those studies which 
addressed the SARS pandemic (the bulk of the retrieved literature). The SARS-only 
prevalence meta-analysis for acute PTSS yielded a pooled prevalence estimate of 19.7% 
(95% CI 13.1, 27.4; k=7; N= 2813; Chan et al. 2004, Chen et al. 2005, Lin et al. 2007, 
Maunder et al. 2004, Sim et al. 2004, Sin et al. 2004, Su et al. 2007), only slightly less than 
the estimate for all studies. There remained a large degree of heterogeneity (Q[6] = 159.51, 
p<.0001; I2 = 93.8%). The SARS-only prevalence meta-analysis for acute general psychiatric 
screening cases yielded a pooled prevalence estimate of 39.1% (95% CI 23.9, 55.6; k=7; 
N=3502; Chan et al. 2004, Chong et al. 2004, Lin et al. 2007, Nickell et al. 2004, Sim et al. 
2004, Sin et al. 2004, Tam et al. 2004), a slightly higher than figure than that obtained for all 
studies. Again, this did not improve heterogeneity, which remained large (Q[6])=749.37, 
p.0001; I2=99.8%). 
Second, meta-analyses that used only the same measure were undertaken. For the IES 
(PTSS)16, a point estimate of 21.0% was obtained (95% CI 11.7, 32.0; k=4; N= 2351; 
Q[3]=87.25, p<.0001; I2=95.7%; Chan et al. 2004, Chen et al. 2005, Maunder et al. 2004, Sin 
et al. 2004). For the IES-R17 a point estimate of 26.6% was obtained (95% CI 9.4, 48.7; k=3; 
N=1611; Q[2]=97.67, p<.0001; I2=97.9%; Lai et al. 2020, Lee et al. 2018, Sim et al. 2004). 
For the GHQ-2818 a point estimate of 17.7 (95% CI 9.3, 28.1; k=4; N=1462; Q[3]=87.60, 
p<.0001; I2=94.9%; Chan et al. 2004, Goulia ea al. 2010, Sim et al. 2004, Sin et al. 2004). 
For each analysis there remained a large degree of heterogeneity.  
It is noteworthy that even when restricting analyses to a single measure (e.g. IES, 
IES-R, GHQ-28), different cut-off scores were used to denote caseness. For example, if the 
point estimate GHQ-28 in the acute phase was restricted to studies that used a cut-off score of 
5, a point estimate of 23.4% was obtained (95% CI 18.6, 28.5; k=3; N=993; Chan et al. 2004, 
Sim et al. 2004, Sin et al. 2004) that did not have significant heterogeneity (Q[2]=4.88, 
p=0.087; I2=58.7%). 
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Discussion 
 
The studies identified in this rapid systematic review and meta-analysis 
predominantly addressed clinically significant PTSS and general psychiatric caseness in 
HCW in the acute phase, i.e. during and immediately after a pandemic. Fewer studies 
addressed longer-term follow up. The majority of the studies considered the SARS pandemic. 
Our findings suggest that a significant minority of HCWs met threshold for clinically 
significant PTSS and general psychiatric caseness in the acute phase, with no apparent 
differences between doctors and nurses with respect to either outcome. However, a precise 
estimate of either PTSS and general psychiatric caseness cannot be derived from the 
reviewed literature given the large of heterogeneity in study findings.  
The limited data from follow up studies suggested that there was a lower rate of PTSS 
several months after a pandemic (in particular SARS). Only two studies addressed PTSS rates 
more than 12 months post-pandemic and the results demonstrated significant heterogeneity. 
Both studies were large (>500 participants) and yielded a reasonably precise estimate of 
PTSS prevalence (95% CI 8.4-15.8%) that was markedly lower than the (albeit more 
imprecise) estimate for the acute phase. Whilst this could indicate a reduction in PTSS over 
time, it is important to stress that the lower number of follow-up studies and the high 
heterogeneity within the included studies makes comparison between time points very 
difficult; as such an apparent reduction in PTSS should be considered with caution. 
For general psychiatric screening the picture was not clear. While two studies 
suggested an improvement by the time of the 6-12 month post-pandemic window, there was 
considerable heterogeneity at the time on the 12 months onwards timeframe. We would 
highlight the potential contribution to between-study heterogeneity of using different cut-offs 
in screening instruments. The one study to use structured interview assessments at follow-up 
found very low rates of psychiatric disorder that might be directly attributable to HCW 
experiences during a pandemic. 
We found that PTSS were elevated during the acute phase and at 12 months, similar 
to existing populations of at-risk health workers such as rescue workers (10%)19, paramedics 
(11%)20, and HCWs in general (14.8%)21 who report higher levels of PTSS than the general 
population (e.g. 3.5%)22. Whilst there were very limited data pertaining to the course of 
clinically-significant PTSS, our findings may be considered broadly consistent with the 
existing literature that suggests natural recovery is common in trauma-exposed individuals.23 
24  
However, it is likely that the COVID may have a longer, ongoing acute phase than in 
those studies reviewed such staff may have longer exposure to stress whilst experiencing 
PTSS.  Furthermore, it is possible that COVID-19 represents a degree of threat more serious 
than that from previous pandemics due to factors including lack of personal protective 
equipment, impaired systemic resilience factors related to social distancing and uncertainties 
around the duration of the pandemic. As such, our findings may provide an under-estimate. 
Comparison with a recent review of HCWs exposed to COVID-1925 is appropriate. This 
systematic review and meta-analysis found that 23.3% and 22.8% HCWs working during the 
first few months of the COVID-19 pandemic experienced symptoms of anxiety and 
depression respectively, as well as 38.9% experiencing insomnia. Sex and occupational 
differences were also reported within the sample, with female HCWs reporting increased 
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symptoms compared to male medical staff. These findings suggest a slight increase in the 
prevalence of depression compared with the findings of the present review. 
 A recent position paper called for high-quality research on the mental health effects of 
COVID-19 within vulnerable groups, including HCW26. With respect to clinical care for 
HCWs, these findings underline the need to consider closely the mental health needs of this 
workforce, particularly given how frequent acute mental health disturbance may be. In 
themselves, such acute reactions to pandemics may be not be classed as “disorders” given the 
very real threat that close clinical contact with infected patients may present. Whilst these 
reactions are considered normal, it is imperative to consider how best to support staff during 
the ongoing crisis, including how to detect persistent PTSD early. An “active monitoring” 
approach as proposed by the UK NICE guidelines for PTSD27 or a screen and treatment 
approach as used in response to other major incidents28 may be advisable for HCWs 
experiencing an acute PTSS reaction. Indeed, the persistence of PTSS, and the emergence of 
what may be properly classed as disorders, is not well understood in this population and 
service planning for HCWs may need to draw on estimates drawn from other trauma-exposed 
populations. Moreover, our findings demonstrate the variety of screening tools and cut-off 
scores that have been be used to determine “caseness”. Clinically, services that use such tools 
need to careful about the use of screening instruments to identify at-risk staff, and the 
potential impact of even small differences in cut-offs. 
This review highlights the need for urgent research to include more extensive follow 
up, in particular using prospective longitudinal cohorts of HCWs, and consider disorders 
other than PTSS; depression in particular has received very limited attention. While screening 
instruments for outcomes like PTSS and depression have obvious benefits in terms of cost-
effectiveness, they may also miss key aspects of HCW experience and may fail to consider 
the impact of other factors, e.g. prior or non-healthcare traumatic experiences. Other aspects 
of health and well-being (e.g. substance abuse, functioning) were not considered in detail. 
Though some longer versions of the GHQ/CHQ do include items relating to social 
functioning, these were not normally presented separately. More detailed assessment (e.g. 
using structured interviews), similar to that undertaken by Lancee and colleagues14 may be 
warranted. It was beyond the scope of the present rapid review to identify risk factors for 
mental health disorders. Although we were able to consider differences in prevalence for two 
professions (doctors and nurses), the needs of other HCWs, and allied professions and 
hospital staff also need to be addressed in detail.  
This study is strengthened by its inclusion of studies addressing clinically similar 
situations, its detailed coverage of methodological issues and its a priori definition of time 
windows. The study is limited by the limited available data and its heterogeneity, and the 
relative narrowness of outcomes the literature has addressed (e.g. sex differences could not be 
considered).  
 
Conclusion 
There is evidence that HCWs working in pandemics are at increased risk of a range of 
adverse mental health outcomes, at least in the acute phase; two studies suggesting elevated 
rates of clinically significant PTSS at follow up. Research is needed to understand the long-
term effects of psychological stress and trauma on HCWs during COVID and how best to 
support HCWs during and after the pandemic.  
12 
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Table 1. Study characteristics  
Study Epidemic N % Female Country Staff 
type 
Mental health 
intervention reported? 
PTSD measure General 
psychiatric screen 
Depression 
measure  
Anxiety 
measure 
Study 
quality 
Chan et al. (2004) SARS 661 NR Singapore Mixed Existing Peer Support 
Programme 
IES (≥30) GHQ-28 (≥5) - - Medium 
Chen et al. (2005) SARS 86 100 Taiwan Nurses No IES (≥35) - - - High 
Chong et al. (2004) SARS 1257 81.1 Taiwan Mixed  Group debriefing - CHQ-12 (≥3) - - Medium 
Goulia et al. (2010) H1N1 469 68.4 Greece Mixed  No - GHQ-28 (≥11) - - Low 
Jung et al. (2020) MERS 147 100 South Korea Nurses No IES-R (Korean) (≥18) - - - Medium 
Lai et al. (2020) Covid-19 1257 76.7 China Mixed  Psychological 
assistance services 
IES-R (≥26) - PHQ-9 (≥10) GAD-7 (≥7) High 
Lee et al. (2018) MERS 77 90 South Korea Mixed  No IES-R (≥25) - - - Low 
Lin et al. (2007) SARS 92 91.3 Taiwan Mixed  No DTS (≥40) CHQ-12 (≥3) - - High 
Liu et al. (2012) SARS 549 75 China Mixed No IES-R (≥20) - CES-D (≥25) - High 
Lu et al. (2006) & Lung et al. 
(2009) 
SARS 127a  58 Taiwan Mixed  No - CHQ-12 (≥3) - - High 
Maunder et al. (2004) SARS 1557 NR Canada Mixed No IES (≥20) - - - Medium 
Maunder et al. (2006) SARS 587 86 Canada Mixed No IES (≥26) K-10 (≥16) - - Medium 
Nickell et al. (2004) SARS 510 78.8 Canada Mixed No - GHQ-12 (≥3) - - Medium 
Phua et al. (2005) SARS 96 69 Singapore Mixed Yes (not described) IES (≥26) GHQ-28 (≥5) - - High 
Sim et al. (2004) SARS 277 85.2 Singapore Mixed No IES-R (diagnosis) GHQ-28 (≥5) - - High 
Sin et al. (2004) SARS 47 NR Singapore Mixed No IES (≥30) GHQ-28 (≥5) - - Medium 
Su et al. (2007) SARS 102 NR Taiwan Nurses No DTS (≥23)  - BDI (≥10) - High 
Tam et al. (2004) SARS 652 79 Hong Kong  Mixed No - CHQ-12 (≥3) - - Medium 
 
Notes. Cut-offs for each measure are reported in parentheses. a123 at follow up. BDI = Beck Depression Inventory; CES-D = Center for Epidemiological Studies Depression Scale; CHQ = 
Chinese Health Questionnaire; DTS=Davidson Trauma Scale; GAD-7 = Generalised Anxiety Disorder Assessment; GHQ = General Health Questionnaire; IES = Impact of Events Scale; IES-R 
= Impact of Events Scale-Revised; K10=Kessler Psychological Distress Scale; NR = not reported. 
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Figure 1. PRISMA flowchart.  
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Figure 2. Forest plot showing prevalence of PTSS by time window.  
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Figure 3. Forest plot showing prevalence of General Psychiatric Screening by time window. 
